249 related articles for article (PubMed ID: 28647886)
1. Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors.
Pridgeon MG; Grohar PJ; Steensma MR; Williams BO
Curr Osteoporos Rep; 2017 Aug; 15(4):239-246. PubMed ID: 28647886
[TBL] [Abstract][Full Text] [Related]
2. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
3. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
Cai Y; Cai T; Chen Y
J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
[TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
5. Wnt Signaling in Osteosarcoma.
Singla A; Wang J; Yang R; Geller DS; Loeb DM; Hoang BH
Adv Exp Med Biol; 2020; 1258():125-139. PubMed ID: 32767238
[TBL] [Abstract][Full Text] [Related]
6. The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling.
Hawkins AG; Basrur V; da Veiga Leprevost F; Pedersen E; Sperring C; Nesvizhskii AI; Lawlor ER
Mol Cell Proteomics; 2018 May; 17(5):901-912. PubMed ID: 29386236
[TBL] [Abstract][Full Text] [Related]
7. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
9. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
10. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switch.
Hawkins AG; Pedersen EA; Treichel S; Temprine K; Sperring C; Read JA; Magnuson B; Chugh R; Lawlor ER
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32544094
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
[TBL] [Abstract][Full Text] [Related]
14. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
15. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model.
Goldstein SD; Trucco M; Bautista Guzman W; Hayashi M; Loeb DM
Oncotarget; 2016 Apr; 7(16):21114-23. PubMed ID: 27049730
[TBL] [Abstract][Full Text] [Related]
17. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway.
Liu X; Geng Z; Ding X; Lou Y; Zhang X
Bioengineered; 2022 May; 13(5):13280-13292. PubMed ID: 35635031
[TBL] [Abstract][Full Text] [Related]
18. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
[No Abstract] [Full Text] [Related]
19. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
20. Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells.
Chen C; Zhao M; Tian A; Zhang X; Yao Z; Ma X
Oncotarget; 2015 Jul; 6(19):17570-83. PubMed ID: 25999350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
